Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001144204-13-008670
Filing Date
2013-02-14
Accepted
2013-02-14 11:08:45
Documents
1
Group Members
ARTHUR COHENHEALTHCOR ASSOCIATES, LLCHEALTHCOR GROUP, LLCHEALTHCOR HYBRID OFFSHORE GP, LLCHEALTHCOR HYBRID OFFSHORE MASTER FUND, L.P.HEALTHCOR LONG MASTER GP, LLCHEALTHCOR LONG OFFSHORE MASTER FUND, L.P.HEALTHCOR OFFSHORE GP, LLCHEALTHCOR OFFSHORE MASTER

Document Format Files

Seq Description Document Type Size
1 SC 13G/A v335153_sc13ga.txt SC 13G/A 38573
  Complete submission text file 0001144204-13-008670.txt   40520
Mailing Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710
Business Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710 5108485100
DYNAVAX TECHNOLOGIES CORP (Subject) CIK: 0001029142 (see all company filings)

EIN.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-80035 | Film No.: 13607882
SIC: 2834 Pharmaceutical Preparations

Mailing Address 152 WEST 57TH STREET 43RD FLOOR NEW YORK NY 10019
Business Address 152 WEST 57TH STREET 43RD FLOOR NEW YORK NY 10019 212-622-7871
HealthCor Management, L.P. (Filed by) CIK: 0001343781 (see all company filings)

EIN.: 202893581 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A